GlassScriptPhysician profile
Eric F Calfee
NPI 1104927466
$1,077.50
in general payments reported to CMS, 2019-2025
27 companies · $203 in 2025
The $203 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $388 · 2020: $42.87 · 2021: $18.80 · 2022: $89.72 · 2023: $116 · 2024: $218 · 2025: $203.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $538.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $537.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $157.01 | 2019-2024 | |
| Abbvie INC. | $127.96 | 2019-2021 | |
| Aspira Women'S Health INC | $78.83 | 2023-2024 | Ova1 |
| Medtronic, INC. | $74.93 | 2022-2024 | Interstim |
| Astellas Pharma US INC | $72.69 | 2019-2024 | Veozah |
| Exeltis, USA INC. | $65.70 | 2023-2025 | Slynd |
| Shield Therapeutics INC | $54.13 | 2022-2025 | |
| Biogen, INC. | $49.47 | 2024-2025 | Zurzuvae |
| Therapeuticsmd, INC. | $36.66 | 2019 | |
| Pfizer INC. | $33.81 | 2020-2024 | |
| Sumitomo Pharma America, INC. | $33.26 | 2025 | Myfembree |
| Becton, Dickinson and Company | $30.45 | 2025 | Arista |
| Allergan, INC. | $30.16 | 2019 | |
| Amag Pharmaceuticals, INC. | $23.54 | 2019 | |
| Bausch Health US, LLC | $23.53 | 2022 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $22.03 | 2025 | General - Female Sui |
| Novo Nordisk INC | $18.94 | 2023 | Wegovy |
| Lsi Solutions INC | $18.11 | 2024 | Fornisee |
| Axonics, INC. | $16.24 | 2024 | Axonics, Bulkamid |
| Bayer Healthcare Pharmaceuticals INC. | $16.06 | 2020 | |
| Ambu INC. | $15.56 | 2024 | |
| Lilly USA, LLC | $15.29 | 2025 | Zepbound |
| Avion Pharmaceuticals | $13.20 | 2022 | |
| Covidien LP | $13.17 | 2019 | |
| Minerva Surgical, INC | $13.03 | 2023 | |
| Dysis Medical, INC. | $12.84 | 2022 | |
| Hologic Sales and Service, LLC | $10.90 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Calfee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.